These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 20527061)

  • 21. Lack of efficacy of prophylactic platelet transfusion for severe thrombocytopenia in adults with acute uncomplicated dengue infection.
    Lye DC; Lee VJ; Sun Y; Leo YS
    Clin Infect Dis; 2009 May; 48(9):1262-5. PubMed ID: 19292665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical evaluation of platelet transfusions in thrombocytopenic patients: methods and interpretation.
    Kahn RA
    Vox Sang; 1981; 40 Suppl 1():87-97. PubMed ID: 7293125
    [No Abstract]   [Full Text] [Related]  

  • 23. Hypoplastic thrombocytopenia and platelet transfusion: therapeutic goals.
    Karakatsanis SJ; Papadatos SS; Syrigos KN
    Hosp Pract (1995); 2019 Feb; 47(1):16-23. PubMed ID: 30409035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. They took a mulligan and mostly got it right … the issue of prophylactic platelet transfusion for patients receiving autologous stem cell transplantation.
    Schiffer CA
    Transfusion; 2014 Oct; 54(10):2372-4. PubMed ID: 25302734
    [No Abstract]   [Full Text] [Related]  

  • 25. The blood bank physician as a hemostasis consultant.
    Sweeney JD
    Transfus Apher Sci; 2008 Oct; 39(2):145-50. PubMed ID: 18760674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fecal blood loss: A quantitative method of evaluating hemostasis in patients with thrombocytopenia.
    Slichter SJ; Gernsheimer T; LeBlanc R; Townsend-McCall D; Jones MK; Cuaron L; Bolgiano D
    Transfusion; 2021 Feb; 61(2):393-403. PubMed ID: 33166412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thrombocytopenia and platelet transfusions in patients with cancer.
    Valent J; Schiffer CA
    Cancer Treat Res; 2011; 157():251-65. PubMed ID: 21052961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of prophylactic transfusions using single donor apheresis platelets versus pooled platelet concentrates in AML/MDS patients receiving allogeneic hematopoietic stem cell transplantation.
    Gurkan E; Patah PA; Saliba RM; Ramos CA; Anderson BS; Champlin R; de Lima M; Lichtiger B
    Bone Marrow Transplant; 2007 Sep; 40(5):461-4. PubMed ID: 17589530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Template bleeding times of 240 neonates born at 24 to 41 weeks gestation.
    Del Vecchio A; Latini G; Henry E; Christensen RD
    J Perinatol; 2008 Jun; 28(6):427-31. PubMed ID: 18273029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Individualized treatment for immune thrombocytopenia: predicting bleeding risk.
    Neunert CE
    Semin Hematol; 2013 Jan; 50 Suppl 1():S55-7. PubMed ID: 23664518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet transfusion goals in oncology patients.
    Fasano RM; Josephson CD
    Hematology Am Soc Hematol Educ Program; 2015; 2015():462-70. PubMed ID: 26637759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Compliance with prophylactic platelet transfusion trigger in haematological patients.
    Eikenboom JC; van Wordragen R; Brand A
    Transfus Med; 2005 Feb; 15(1):45-8. PubMed ID: 15713128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet transfusions.
    Kelton JG; Blajchman MA
    Can Med Assoc J; 1979 Nov; 121(10):1353-8. PubMed ID: 391376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet transfusion refractoriness.
    Hod E; Schwartz J
    Br J Haematol; 2008 Jul; 142(3):348-60. PubMed ID: 18510692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Indications and contraindications for platelet transfusions in patients with thrombocytopenia].
    Tomicić M; Vuk T; Hundrić-Haspl Z
    Lijec Vjesn; 2014; 136(3-4):90-3. PubMed ID: 24988744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A therapeutic platelet transfusion strategy is safe and feasible in patients after autologous peripheral blood stem cell transplantation.
    Wandt H; Schaefer-Eckart K; Frank M; Birkmann J; Wilhelm M
    Bone Marrow Transplant; 2006 Feb; 37(4):387-92. PubMed ID: 16400342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What is the proper threshold for platelet transfusion in patients with chemotherapy-induced thrombocytopenia?
    Benjamin RJ; Anderson KC
    Crit Rev Oncol Hematol; 2002 May; 42(2):163-71. PubMed ID: 12007974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute bleeding complications in patients after hematopoietic stem cell transplantation with prophylactic platelet transfusion triggers of 10 x 10(9) and 20 x 10(9) per L.
    Nevo S; Fuller AK; Hartley E; Borinsky ME; Vogelsang GB
    Transfusion; 2007 May; 47(5):801-12. PubMed ID: 17465944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treating thrombocytopenia with pathogen-reduced platelets.
    Sandler SG
    Curr Hematol Rep; 2006 Mar; 5(1):53-4. PubMed ID: 16537046
    [No Abstract]   [Full Text] [Related]  

  • 40. Primary hemostasis after massive transfusion for injury.
    Harrigan C; Lucas CE; Ledgerwood AM; Mammen EF
    Am Surg; 1982 Aug; 48(8):393-6. PubMed ID: 7114608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.